Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    National Security
    Science & Regulatory
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    .
    Human Health
    Startups
    .
    Non-R&D Companies
    Member Savings
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Investor Forum
    BIO Asia-Taiwan

    July 15-19, 2026
    Taipei, Taiwan

    BIO Patient & Health Advocacy Summit
    BIO Patient Advocacy Changemakers Event

    October 22-23, 2026
    Washington, D.C

    BIO Asia-Taiwan
    BIO Europe

    November 9-11, 2026
    Cologne, Germany

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyNational SecurityScience & RegulatoryAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3232 results found
Expand All
Apply All
3232 results found

BIO Comments on OMB Proposed Rule "Regulation for Federal Financial Assistance"
Share
Letters, Testimony & Comments  •  July 13, 2026

CSBA News, Comments, and Letters
Share
Council for State Biotechnology Associations (CSBA)

CSBA Letter to OMB
Share
Letters, Testimony & Comments  •  July 13, 2026
CSBA Letter to OMB

Are we finally ready for 340B reform?
Share
Bio.News  •  July 13, 2026
A flurry of congressional activity brings hope of 340B reform. Meanwhile, BIO comments on clinical trial reform. (665 words, 2 minutes, 40 seconds)
Read More

BIO Events
Share
Business Development

Secure File Sharing & Protection
Share
BIO Business Solutions - Program
A Smarter Way to Share Sensitive Information — Built for Life Sciences Vetted by BIO. Trusted by Investors. Ready When You Are.Whether you’re prepping for a partner meeting, managing trial data, or organizing a regulatory submission, how you share sensitive information can make or break the outcome.ShareVault is the only secure document-sharing platform endorsed by BIO and 44 life science associations, designed specifically to meet the needs of companies like yours. Investors Take You More Seriously When You’re Using ShareVaultWhen your documents are organized, accessible, and professionally presented, it shows. ShareVault helps you deliver exactly what investors, partners, and regulators need to see—without the chaos or confusion. Let’s Get You Set UpMembers can start with a free 1-month trial, and we’ll handle the heavy lifting. Migration, setup, structure—done. Download for more detailsMember benefits, exclusive discounts, and more.   Start your Free Trial Now Available exclusively to BIO & State Association Members.
Read More

Insurance and Benefits Broker
Share
BIO Business Solutions - Program
About NFP, an Aon CompanyLife science companies face complex and evolving risk—across clinical development, global operations, data, and governance. NFP works alongside leadership teams to help identify, structure, and manage risk across every stage of growth.Through BIO's collaboration with NFP, eligible BIO and state life science association members can access NFP’s specialized capabilities, market reach, and advisory support—at preferential program pricing.
Read More

340B and PASTEUR Act - plus, more from BIO 2026
Share
Bio.News  •  June 29, 2026
ICYMI: The PASTEUR Act was reintroduced in the Senate. Plus, more from BIO 2026, including the latest on the 340B program and what the media was covering at the Convention. (639 words, 3 minutes, 12 seconds)
Read More

BIO 2026: Patients, patents, and biotech's next decade
Share
Bio.News  •  June 26, 2026
As BIO 2026 comes to a close, we look ahead to biotech's sixth decade. Pioneering patients remind us why innovation matters, and experts outline what will shape biotech's next decade, and leaders warn that protecting intellectual property remains essential to American biotech leadership. (882 words, 4 minutes, 25 seconds)
Read More

BIO 2026: What's driving America's biotech future?
Share
Bio.News  •  June 25, 2026
Day 3 of BIO 2026 looked ahead to biotech's next chapter: how AI could accelerate drug discovery, why U.S. biotechnology leadership is a national security priority, and what states can do to compete for the industry's next generation of growth. (670 words, 3 minutes, 14 seconds)
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 9
  • 10
  • 11
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO Investment and Growth Summit
BIO Partnering™ for Oncology
BIO International Convention
BIO Partnering™ at JPM Week
BIO Patient Advocacy Changemakers Events
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2026 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO